helixpath bpc 157 What Science ACTUALLY Says About Benefits BPC-157 — ≥99% Purity, COA

London: Chapman and Hall, 1991

The practical takeaway: Injection = high systemic distribution tendons, ligaments, muscle, joints, vascular tissue Oral = high local GI concentration intestinal lining, gastric mucosa, gut repair Nasal = intermediate systemic delivery potential neurological targeting, emerging evidence only Injectable BPC-157: Highest Bioavailability for Systemic and Musculoskeletal Goals Injectable BPC-157 is the best-studied delivery method for healing applications outside the gastrointestinal tract

You should change your activity or sport to allow the tendon time to heal

This is crucial for anyone with conditions that impair nutrient absorption from food or pills